Hepatology 46 , 13921403 (2007)
Coverage may be available for eligible patients prescribed Wegovy, Zepbound, Ozempic, Mounjaro, semaglutide, or tirzepatide
Currently, there is no official contraindication listed in the Summary of Product Characteristics (SmPC) that specifically prohibits the use of semaglutide in patients with inflammatory bowel disease (IBD), including Crohn's disease
+2 to +8 C Transport temp
Make sure to refer to the BUD on your medication's packaging
We do not directly offer medical or pharmacy services, and payment does not guarantee that a prescription will be written or medication dispensed